Marie-France Savard

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 28

Top Topics

Positive Breast Cancer

Top Venues

Current oncology (Toronto, Ont.)

JCO clinical cancer informatics

This page only lists publications with an associated author ORCID identifier.

Publications

Sharon F McGee, Mark J Clemons, Gregory Russell Pond, Jean-Michel Caudrelier, Michelle Liu, Mashari Jemaan Alzahrani, Terry L Ng, Arif A Awan, Sandeep R Sehdev, John Hilton, Marie-France Savard, Lesley Fallowfield, Vikaash Kumar, Orit Freedman, Lisa Vandermeer, Brian Hutton, Jean-Marc Bourque
A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast Cancer. Current oncology (Toronto, Ont.) 31 (8) (2024)
Ana-Alicia Beltran-Bless, Mark J Clemons, Lisa Vandermeer, Khaled El Emam, Terry L Ng, Sharon McGee, Arif Ali Awan, Gregory Pond, Julie Renaud, Gwen Barton, Brian Hutton, Marie-France Savard
The REthinking Clinical Trials Program Retreat 2023: Creating Partnerships to Optimize Quality Cancer Care. Current oncology (Toronto, Ont.) 31 (3) (2024)
Ana-Alicia Beltran-Bless, Mark J Clemons, Lisa Vandermeer, Khaled El Emam, Terry L Ng, Sharon McGee, Arif Ali Awan, Gregory Pond, Julie Renaud, Gwen Barton, Brian Hutton, Marie-France Savard
The REthinking Clinical Trials Program Retreat 2023: Creating Partnerships to Optimize Quality Cancer Care. Current oncology (Toronto, Ont.) 31 (3) (2024)
Parvaneh Fallah, Lucas Clemons, Michelle Bradbury, Lisa Vandermeer, Mark J Clemons, Julie Renaud, Marie-France Savard
Evaluation of Unsolicited Feedback from Patients with Cancer and Their Families as a Strategy to Improve Cancer Care Delivery. Current oncology (Toronto, Ont.) 31 (5) (2024)
Parvaneh Fallah, Lucas Clemons, Michelle Bradbury, Lisa Vandermeer, Mark J Clemons, Julie Renaud, Marie-France Savard
Evaluation of Unsolicited Feedback from Patients with Cancer and Their Families as a Strategy to Improve Cancer Care Delivery. Current oncology (Toronto, Ont.) 31 (5) (2024)
Parvaneh Fallah, Lucas Clemons, Michelle Bradbury, Lisa Vandermeer, Mark J Clemons, Julie Renaud, Marie-France Savard
Evaluation of Unsolicited Feedback from Patients with Cancer and Their Families as a Strategy to Improve Cancer Care Delivery. Current oncology (Toronto, Ont.) 31 (5) (2024)
Ana-Alicia Beltran-Bless, Mark J Clemons, Lisa Vandermeer, Khaled El Emam, Terry L Ng, Sharon McGee, Arif Ali Awan, Gregory Pond, Julie Renaud, Gwen Barton, Brian Hutton, Marie-France Savard
The REthinking Clinical Trials Program Retreat 2023: Creating Partnerships to Optimize Quality Cancer Care. Current oncology (Toronto, Ont.) 31 (3) (2024)
Sarah Cook, Shabbir Muhammad Husayn Alibhai, Rajin Mehta, Marie-France Savard, Caroline Mariano, Dominique LeBlanc, Danielle Desautels, Rossanna Pezo, Xiaofu Zhu, Karen A Gelmon, Tina Hsu
Improving Care for Older Adults with Cancer in Canada: A Call to Action. Current oncology (Toronto, Ont.) 31 (7) (2024)
Sharon F McGee, Mark J Clemons, Gregory Russell Pond, Jean-Michel Caudrelier, Michelle Liu, Mashari Jemaan Alzahrani, Terry L Ng, Arif A Awan, Sandeep R Sehdev, John Hilton, Marie-France Savard, Lesley Fallowfield, Vikaash Kumar, Orit Freedman, Lisa Vandermeer, Brian Hutton, Jean-Marc Bourque
A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast Cancer. Current oncology (Toronto, Ont.) 31 (8) (2024)
Sarah Cook, Shabbir Muhammad Husayn Alibhai, Rajin Mehta, Marie-France Savard, Caroline Mariano, Dominique LeBlanc, Danielle Desautels, Rossanna Pezo, Xiaofu Zhu, Karen A Gelmon, Tina Hsu
Improving Care for Older Adults with Cancer in Canada: A Call to Action. Current oncology (Toronto, Ont.) 31 (7) (2024)
Ana-Alicia Beltran-Bless, Mark J Clemons, Lisa Vandermeer, Khaled El Emam, Terry L Ng, Sharon McGee, Arif Ali Awan, Gregory Pond, Julie Renaud, Gwen Barton, Brian Hutton, Marie-France Savard
The REthinking Clinical Trials Program Retreat 2023: Creating Partnerships to Optimize Quality Cancer Care. Current oncology (Toronto, Ont.) 31 (3) (2024)
Ana-Alicia Beltran-Bless, Mark J Clemons, Lisa Vandermeer, Khaled El Emam, Terry L Ng, Sharon McGee, Arif Ali Awan, Gregory Pond, Julie Renaud, Gwen Barton, Brian Hutton, Marie-France Savard
The REthinking Clinical Trials Program Retreat 2023: Creating Partnerships to Optimize Quality Cancer Care. Current oncology (Toronto, Ont.) 31 (3) (2024)
Sharon F McGee, Mark J Clemons, Gregory Russell Pond, Jean-Michel Caudrelier, Michelle Liu, Mashari Jemaan Alzahrani, Terry L Ng, Arif A Awan, Sandeep R Sehdev, John Hilton, Marie-France Savard, Lesley Fallowfield, Vikaash Kumar, Orit Freedman, Lisa Vandermeer, Brian Hutton, Jean-Marc Bourque
A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast Cancer. Current oncology (Toronto, Ont.) 31 (8) (2024)
Michelle Bradbury, Marie-France Savard, Lisa Vandermeer, Lucas Clemons, Gregory Pond, John Hilton, Mark J Clemons, Sharon McGee
Shorter Durations of Anti-HER2 Therapy for Patients with Early-Stage, HER2-Positive Breast Cancer: The Physician Perspective. Current oncology (Toronto, Ont.) 30 (12) (2023)
Emily B Jackson, Lauren Curry, Caroline Mariano, Tina Hsu, Sarah Cook, Rossanna C Pezo, Marie-France Savard, Danielle N Desautels, Dominique Leblanc, Karen A Gelmon
Key Considerations for the Treatment of Advanced Breast Cancer in Older Adults: An Expert Consensus of the Canadian Treatment Landscape. Current oncology (Toronto, Ont.) 31 (1) (2023)
Emily B Jackson, Lauren Curry, Caroline Mariano, Tina Hsu, Sarah Cook, Rossanna C Pezo, Marie-France Savard, Danielle N Desautels, Dominique Leblanc, Karen A Gelmon
Key Considerations for the Treatment of Advanced Breast Cancer in Older Adults: An Expert Consensus of the Canadian Treatment Landscape. Current oncology (Toronto, Ont.) 31 (1) (2023)
Michelle Bradbury, Marie-France Savard, Lisa Vandermeer, Lucas Clemons, Gregory Pond, John Hilton, Mark J Clemons, Sharon McGee
Shorter Durations of Anti-HER2 Therapy for Patients with Early-Stage, HER2-Positive Breast Cancer: The Physician Perspective. Current oncology (Toronto, Ont.) 30 (12) (2023)
Samer El Kababji, Nicholas Mitsakakis, Xi Fang, Ana-Alicia Beltran-Bless, Greg Pond, Lisa Vandermeer, Dhenuka Radhakrishnan, Lucy Mosquera, Alexander Paterson, Lois E Shepherd, Bingshu E Chen, William E Barlow, Julie R Gralow, Marie-France Savard, Mark J Clemons, Khaled El Emam
Evaluating the Utility and Privacy of Synthetic Breast Cancer Clinical Trial Data Sets. JCO clinical cancer informatics 7 (2023)
Emily B Jackson, Lauren Curry, Caroline Mariano, Tina Hsu, Sarah Cook, Rossanna C Pezo, Marie-France Savard, Danielle N Desautels, Dominique Leblanc, Karen A Gelmon
Key Considerations for the Treatment of Advanced Breast Cancer in Older Adults: An Expert Consensus of the Canadian Treatment Landscape. Current oncology (Toronto, Ont.) 31 (1) (2023)
Michelle Bradbury, Marie-France Savard, Lisa Vandermeer, Lucas Clemons, Gregory Pond, John Hilton, Mark J Clemons, Sharon McGee
Shorter Durations of Anti-HER2 Therapy for Patients with Early-Stage, HER2-Positive Breast Cancer: The Physician Perspective. Current oncology (Toronto, Ont.) 30 (12) (2023)
Emily B Jackson, Lauren Curry, Caroline Mariano, Tina Hsu, Sarah Cook, Rossanna C Pezo, Marie-France Savard, Danielle N Desautels, Dominique Leblanc, Karen A Gelmon
Key Considerations for the Treatment of Advanced Breast Cancer in Older Adults: An Expert Consensus of the Canadian Treatment Landscape. Current oncology (Toronto, Ont.) 31 (1) (2023)
Michelle Bradbury, Marie-France Savard, Lisa Vandermeer, Lucas Clemons, Gregory Pond, John Hilton, Mark J Clemons, Sharon McGee
Shorter Durations of Anti-HER2 Therapy for Patients with Early-Stage, HER2-Positive Breast Cancer: The Physician Perspective. Current oncology (Toronto, Ont.) 30 (12) (2023)
Michelle Bradbury, Marie-France Savard, Lisa Vandermeer, Lucas Clemons, Gregory Pond, John Hilton, Mark J Clemons, Sharon McGee
Shorter Durations of Anti-HER2 Therapy for Patients with Early-Stage, HER2-Positive Breast Cancer: The Physician Perspective. Current oncology (Toronto, Ont.) 30 (12) (2023)
Michelle Bradbury, Marie-France Savard, Lisa Vandermeer, Lucas Clemons, Gregory Pond, John Hilton, Mark J Clemons, Sharon McGee
Shorter Durations of Anti-HER2 Therapy for Patients with Early-Stage, HER2-Positive Breast Cancer: The Physician Perspective. Current oncology (Toronto, Ont.) 30 (12) (2023)
Sharon F McGee, Mark J Clemons, Marie-France Savard
Evolving Role of Risk Tailored Therapy in Early Stage HER2-Positive Breast Cancer: A Canadian Perspective. Current oncology (Toronto, Ont.) 29 (6) (2022)
Marie-France Savard, Elizabeth N Kornaga, Adriana Matutino Kahn, Robert B Basmadjian
Survival in Women with De Novo Metastatic Breast Cancer: A Comparison of Real-World Evidence from a Publicly-Funded Canadian Province and the United States by Insurance Status. Current oncology (Toronto, Ont.) 29 (1) (2022)
Marie-France Savard, Mashari Jemaan Alzahrani, Deanna Saunders, Lynn Chang, Angel Arnaout, Terry L Ng, Muriel Brackstone, Lisa Vandermeer, Tina Hsu, Ari Ali Awan, Katherine Cole, Gail Larocque, Mark J Clemons
Experiences and Perceptions of Older Adults with Lower-Risk Hormone Receptor-Positive Breast Cancer about Adjuvant Radiotherapy and Endocrine Therapy: A Patient Survey. Current oncology (Toronto, Ont.) 28 (6) (2021)
Mashari Alzahrani, Mark J Clemons, Lynn Chang, Lisa Vendermeer, Angel Arnaout, Gail Larocque, Katherine Cole, Tina Hsu, Deanna Saunders, Marie-France Savard
Management Strategies for Older Patients with Low-Risk Early-Stage Breast Cancer: A Physician Survey. Current oncology (Toronto, Ont.) 29 (1) (2021)